Polaris Venture Management Co. V as of Dec. 31, 2019
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 11 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Phreesia | 62.3 | $86M | 3.2M | 26.64 | |
| Fate Therapeutics (FATE) | 16.2 | $22M | 1.1M | 19.57 | |
| Cardlytics (CDLX) | 9.1 | $13M | 200k | 62.86 | |
| Selecta Biosciences (RNAC) | 4.8 | $6.7M | 2.8M | 2.40 | |
| X4 Pharmaceuticals (XFOR) | 2.4 | $3.3M | 312k | 10.70 | |
| Neuronetics (STIM) | 2.4 | $3.3M | 733k | 4.49 | |
| Kala Pharmaceuticals | 1.5 | $2.1M | 565k | 3.69 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.4 | $545k | 131k | 4.17 | |
| Genocea Biosciences (GNCAQ) | 0.4 | $509k | 246k | 2.07 | |
| Pulmatrix | 0.2 | $309k | 359k | 0.86 | |
| Dare Bioscience (DARE) | 0.2 | $268k | 326k | 0.82 |
